The Patent Finder

Solarea Bio, Inc.

9 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2038
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 24, 2027
    The maintenance fee for Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome (US 11,793,841) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
  • 1 fee due May 21, 2027
    The maintenance fee for Methods and Compositions for Treating Musculoskeletal Diseases (US 11,819,524) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
  • 2 fees due Sep 24 to 26, 2027 · next Sep 24
  • 1 fee due Nov 14, 2027
    The maintenance fee for Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause (US 11,980,647) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,596,209Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
In force
 · USPTO record
In forceUSPTO record
US 11,793,841Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
In force
 · USPTO record
In forceUSPTO record
US 11,819,524Methods and Compositions for Treating Musculoskeletal Diseases
In force
 · Medium confidence
In forceMedium confidence
US 11,980,647Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
In force
 · USPTO record
In forceUSPTO record
US 12,048,722Methods and Compositions for Treating Musculoskeletal Diseases
In force
 · Low confidence
In forceLow confidence
US 11,938,158Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
In force
 · USPTO record
In forceUSPTO record
US 12,440,522Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
In force
 · USPTO record
In forceUSPTO record
US 12,016,891Immunomodulatory Compositions Comprising Microbial Entities
In force
 · Medium confidence
In forceMedium confidence
US 12,440,523Immunomodulatory Compositions Comprising Microbial Entities
In force
 · Low confidence
In forceLow confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 2 abandoned · 3 no status recorded

Showing 1 to 7 of 7, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/304,337Aug 19, 2025No status recorded
19/054,394Microbial Compositions and Methods for Producing Upgraded Probiotic AssemblagesFeb 14, 2025Pending
18/747,158Compositions and Methods for Producing Enhanced Crops with ProbioticsJun 18, 2024Abandoned
18/744,111Methods and Compositions for Treating Musculoskeletal DiseasesJun 14, 2024Pending
18/067,470Dec 16, 2022No status recorded
17/816,932Immunomodulatory Compositions Comprising Microbial EntitiesAug 2, 2022Abandoned
17/555,261Dec 17, 2021No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited